The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2023 | Economic burden of CAR-T therapy from a UK perspective
Andrew Davies, MRCP, PhD, University of Southampton, Southampton, UK, shares some insights into the economic burden associated with CAR-T therapy in the UK, and further comments on the value of the National Institute for Health and Care Excellence (NICE) appraisal system. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
